The Board has considered approved and took on record the unaudited Financial Results (Standalone and Consolidated) of the Company for the 3rd quarter and nine months ended on December 31 2025 including Re-appointment of CEO & MD.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]